BRIEF published on 09/09/2024 at 22:40, 1 year 9 months ago ABIVAX presents its 2024 half-year results Cybersecurity Abivax Half-year Results Internal Control Failures
PRESS RELEASE published on 09/09/2024 at 22:35, 1 year 9 months ago Lettre d'affirmation sur les comptes semestriels 2024 Lettre d'Affirmation Comptes Semestriels Consolidés IFRS de ABIVAX S.A. pour la période du 1 janvier 2024 au 30 juin 2024, validée par PwC Audit et Agili(3F) Audit IFRS Comptes Semestriels ABIVAX S.A. PwC Audit Agili(3F) Audit
PRESS RELEASE published on 09/09/2024 at 22:18, 1 year 9 months ago Rapport financier semestriel 2024
BRIEF published on 09/09/2024 at 22:06, 1 year 9 months ago Résultats financiers d'Abivax pour le premier semestre 2024 Résultats Financiers Biotechnologie Abivax Premier Semestre 2024 Mécanismes Immunitaires
BRIEF published on 09/09/2024 at 22:06, 1 year 9 months ago Abivax financial results for the first half of 2024 Financial Results Biotechnology Abivax First Half Of 2024 Immune Mechanisms
PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 9 months ago Abivax presents first-half 2024 financial results Abivax presents first-half 2024 financial results with a cash balance of EUR 222M at June 30, 2024. The company focuses on developing therapies for chronic inflammatory diseases Financial Results Abivax Therapeutics Chronic Inflammatory Diseases EUR 222M
PRESS RELEASE published on 09/09/2024 at 22:01, 1 year 9 months ago Abivax présente ses résultats financiers du premier semestre 2024 Abivax présente ses résultats financiers semestriels 2024 avec une trésorerie de 222 millions d'euros au 30 juin 2024, assurant le financement jusqu'au Q4 2025 Résultats Financiers Abivax Bilan Trésorerie Dépenses
BRIEF published on 08/29/2024 at 18:05, 1 year 9 months ago ABIVAX : État des actions et des droits de vote au 31 juillet 2024 Euronext Paris Droits De Vote Actions Abivax Réglementaire
BRIEF published on 08/29/2024 at 18:05, 1 year 9 months ago ABIVAX: Status of shares and voting rights as of July 31, 2024 Euronext Paris Voting Rights Actions Abivax Regulatory
PRESS RELEASE published on 08/29/2024 at 18:00, 1 year 9 months ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.07.24. ABIVAX annonce le nombre d'actions et de droits de vote au 31.07.24, conformément aux réglementations en vigueur Euronext Paris Droits De Vote Actions Abivax Règlement Général
Published on 06/22/2026 at 15:58, 3 hours 10 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 3 hours 38 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 4 hours 8 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 5 hours 7 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 5 hours 8 minutes ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 18:54, 13 minutes ago EQS-Adhoc: Brenntag SE publishes preliminary operating EBITDA for the second quarter of 2026 and increases its guidance for the financial year 2026
Published on 06/22/2026 at 18:30, 38 minutes ago Avolta awarded 10-year contract at Orlando International Airport across travel retail and F&B
Published on 06/22/2026 at 18:05, 1 hour 2 minutes ago Bybit EU Strengthens European Positioning Ahead of MiCAR Transition
Published on 06/22/2026 at 18:00, 1 hour 7 minutes ago Zendure Unveils the ZEN+ HOME AI Energy Ecosystem at Intersolar 2026
Published on 06/22/2026 at 18:00, 1 hour 8 minutes ago GUILLEMOT CORPORATION : DECES DE M. CLAUDE GUILLEMOT, Président du Groupe GUILLEMOT CORPORATION
